Skip to main content
Journal of Orthopaedics logoLink to Journal of Orthopaedics
. 2018 Jan 31;15(1):222–225. doi: 10.1016/j.jor.2018.01.021

Early determinants of long-term clinical outcome after cartilage repair surgery in the knee

Eirik Solheim a,b,c,, Janne Hegna b, Eivind Inderhaug a,c
PMCID: PMC5895901  PMID: 29657472

Abstract

Purpose

To identify early determinants of clinical outcome after knee cartilage repair.

Methods

205 patients were evaluated before surgery and at median 14-years follow-up.

Results

Baseline factors predicting a good outcome were: single lesion; normal appearing cartilage surrounding the lesion; high baseline Lysholm score; short duration of symptoms; non-involvement of the patella-femoral joint; young age; and small defect. Factors predicting a poor outcome were: multiple lesions; low baseline Lysholm score; degenerative cartilage surrounding the lesion; long symptom duration; meniscal lesion; and large defect.

Conclusions

The choice of surgical method seem to be less important than other patients-specific predictors.

Level of evidence

Case series, Level IV.

Keywords: Microfracture, Mosaicplasty, Knee, Articular cartilage defects, Arthroscopy

1. Introduction

Focal chondral lesions of the knee are commonly occurring, as displayed by the incidence of 19% in a group of 1000 knee arthroscopies in a prospective study by Hjelle et al.1 Such chondral lesions can have a major impact on patients’ quality of life – in some cases patients have been described to have a reduction in quality of life that is similar to patients that are scheduled for knee replacement.2

Chronic articular cartilage lesions have little or no potential for spontaneously healing and their treatment continues to pose a challenge for orthopaedic surgeons.3, 4 During the last few decades a range of new treatment options have been introduced, including microfracture5, 6 and osteochondral autograft transplantation (OAT) such as mosaicplasty.7 Whereas the short-term results after cartilage repair procedures are acceptable in most patients, few regain normal pain-free function8, 9 and the results seem to deteriorate with time.10, 11, 12 Thus, there is a need to identify (baseline) predictors for the long-term outcome.

Our group has previously presented results for microfracture and mosaicplasty (separately) at short-term, mid-term as well as long-term (10–14 years) after surgery. In the current study, a pooling of all cartilage repair patients was performed with a follow-up of up to 18 years. The main purpose of the study was to relate baseline findings to clinical results at median 14 years after two commonly used cartilage repair techniques to possibly identify determinants of the outcome; good or poor, by calculating risk ratios.

2. Materials and methods

2.1. Patient selection

All patients undergoing a cartilage repair procedure at our institution from 1998 to 2003 were registered prospectively. The data were acquired from standardized forms completed by both the patient and the surgeon. The form contained details about preoperative symptoms and function, perioperative findings and details about the surgery performed – including localisation and size of the articular cartilage defect – similar to the system recommended by the International Cartilage Repair Society.13 The data were stored in a local database (Access, Microsoft Corporation, Redmond, USA).

Patients of age 60 years or younger, at the time of surgery, with symptomatic focal full-thickness chondral lesions verified by arthroscopic examination treated with microfracture or mosaicplasty were included in the study. Exclusion criteria (at the time of surgery) were: joint space narrowing (<4 mm) on standard antero–posterior radiographs, more than 5° varus or valgus malalignment, previous or concurrent realignment surgery, ligament instabilities or inability to follow the rehabilitation protocol.

2.2. Surgical techniques

After an arthroscopic evaluation a microfracture or mosaicplasty procedure was performed. The choice of procedure was done based on the surgeon's preference (and patient's wishes) in each individual case. Mosaicplasty was not used in defects larger than 5 cm2 and not in tibial cartilage lesions.

The lesion was debrided down with curettes to subchondral bone and around the edges until only healthy surrounding cartilage would remain. The area of the lesion was calculated as centimetres squared after measuring the length and width using a meniscal probe.1 The cartilage surrounding the (main) focal full-thickness chondral defect was classified as (A) normal when no sign of degenerative changes were macroscopically visible – or palpable with a probe – during the arthroscopic examination; or (B) slightly abnormal when minor degenerative changes could be detected, i.e., superficial fissures, irregularities, or softening.14, 15

The microfracture procedure was performed as formerly described by Steadman et al.6 Angled awls were used for piercing the subchondral bone plate with holes 3–4 mm apart. The flow of marrow elements from the openings was verified by stopping the inflow of fluid to the joint. The mosaicplasty procedure (Smith and Nephew Inc., Andover, MA, USA) was performed as described by Hangody et al. 7, 16 Grafts were harvested from the periphery of the femoral condyles at the level of the patello-femoral joint and transplanted to correspondingly sized burr holes in the defect. Usually, the procedure was performed using a mini-arthrotomy. In small defects of the femoral condyle an arthroscopic approach was used. In lesions of the patello-femoral joint a large arthrotomy with luxation of the patella was used.

2.3. Rehabilitation

For both procedures, continuous passive motion was started within a few hours after the operation and was continued for 4–7 days (the duration of the stay in hospital). The patients were instructed in the use of crutches by a physiotherapist and maintained foot-touch weight bearing for 6 weeks, thereafter full weight-bearing was gradually introduced. Physiotherapy was commenced at the hospital and continued after the discharge. Initial exercises included stretching, straight-leg rises and passive motion – progressing gradually through active closed-chain exercises including stationary bicycling to dynamic weight training.17 The Ethical Committee at our institution reviewed and approved of the study (HDS ID 1998-0201). All patients gave their informed consent prior to inclusion in the study.

2.4. Outcome measures

Outcome evaluation was performed by the Lysholm score.18, 19 Data were prospectively collected before the operation and at several time-points after, for the first few years at routine check-ups at the out-patient department, thereafter by completing and returning standardized questionnaires sent by mail every 2–3 years, most recently in 2016. In deceased patients, the most recent Lysholm score was used for the calculations (and the corresponding follow-up time recorded). Patients having undergone a knee replacement (after the cartilage repair surgery), were defined as failures and the time of replacement surgery was used for calculating the follow-up time.20

2.5. Statistical analyses

As measures of central location and spread of data, mean and standard deviation (SD) or median and range were calculated based on the type of data. For examining determinants of either a poor result (Lysholm score <64) or a good or excellent result (Lysholm score 80 or greater) two sets of calculations were performed, one for each outcome.18, 19 All predictors were converted into dichotomous data. The odds ratio (OR) and 95% confidence interval (CI) for each predictor were calculated. The statistical analyses were performed with the Statistical Package for the Social Sciences (SPSS Inc., Chicago, Illinois, USA) on a personal computer. A predictor with a value of P < 0.05 was considered to be statistical significant as tested by chi-square statistics.

3. Results

Two hundred and five patients were eligible for inclusion in the study. We were able to record at least one follow-up (at one year or longer) in all patients (100%), 42% women and 58% men, aged median 37 (range, 15–60) years. We used the most recent follow-up data for the calculations. The follow-up time (of the total population) was median 14 (range, 1–18) years. Five patients were deceased during the study period, from 2 to10 years (median 7) after having been included. Twenty-three patients had undergone a knee replacement procedure and were defined as failures. The time of the replacement was recorded as the last follow-up, median 10 (range, 2–18) years. One hundred and twenty-one knees were treated by the microfracture technique, whilst 84 cases had a mosaicplasty performed.

At the time of surgery, median symptom duration was 60 months (range 1–360). The right knee (62%) was more often treated than the left knee (38%). The treated lesion, or the largest of multiple treated lesions, was located on the medial femoral condyle (57%), trochlea (15%), patella (15%), lateral femoral condyle (7%) or lateral tibia (6%). We treated one (75%), two (21%) or three (4%) lesions with a median defect size of 3.5 cm2 (range 1–17). In 46 cases (22%) previous or concurrent partial medial meniscectomy (in the ipsilateral knee) had been performed. At the time of the index surgery 100 cases (49%) had signs of mild degenerative changes in the cartilage surrounding the treated defect.

The statistical significant factors for predicting a good or excellent result, defined as Lysholm score 80 or higher were: A single cartilage lesion, OR = 4.04; normal appearing cartilage surrounding the lesion, OR = 2.77; high baseline Lysholm score (50 or higher), OR = 2.71; duration of symptoms <36 months, OR = 2.45; non-involvement of the patella-femoral joint, OR = 2.27; young age at surgery (25 years or less), OR = 2.23; and defect size 3 cm2 or smaller, OR = 2.20 (Table 1). The following analysed factors did not significantly predict a good or excellent result: Surgical technique (microfracture versus mosaicplasty) (P = 0.2); gender (P = 0.2); right versus left knee (P = 0.4); history of knee trauma (or not) (P = 0.4); or meniscal lesion or not (P = 0.5).

Table 1.

Predictors of a good or excellent outcome (Lysholm score 80 or higher) by odds ratio.

Predictors P-value Odds ratio 95% CI
Single lesion (N = 152) 0.002* 4.041 1.618−10.093
Normal surround. cartilage (N = 104) 0.001* 2.774 1.469−5.240
High baseline Lysholm (N = 91) 0.001* 2.711 1.459−5.039
Duration (months)<36 (N = 66) 0.005* 2.452 1.300−4.628
Not patello-femoral joint (N = 145) 0.027* 2.274 1.086−4.760
Age at surgery 25 or less (N = 29) 0.047* 2.230 0.998−4.985
Small size 3 cm2 or less (N = 88) 0.011* 2.204 1.195−4.062
*

Statistical significant difference.

The statistical significant factors for predicting a poor result (Lysholm score <64 points or having had an ipsilateral knee replacement) were: multiple (2 or 3) lesions, OR = 2.84; low baseline Lysholm score (<50), OR = 2.48; mild degenerative cartilage surrounding the lesion, OR = 2.31; symptom duration of 36 months or more, OR = 2.02; partial meniscectomy, OR = 1.90; and defect size 4 cm2 or larger, OR = 1.77 (Table 2). The following analysed factors did not significantly predict a poor result: Surgical technique (microfracture versus mosaicplasty) (P = 0.2); age at surgery (P = 0.8); gender (P = 0.08); right versus left knee (P = 0.5); involvement of the patello-femoral joint (P = 0.2); or history of knee trauma (or not) (P = 0.9).

Table 2.

Predictors of a poor result (knee replacement and/or Lysholm score <64) by odds ratio.

Predictors P-value Odds ratio 95% CI
Multiple lesions (N = 53) 0.002* 2.840 1.451–5.561
Low baseline Lysholm (N = 114) 0.002* 2.478 1.407–4.365
Degen. of surround. cartilage (N = 96) 0.003* 2.305 1.315–4.039
Duration (months) 36+ (N = 139) 0.021* 2.020 1.106–3.688
Meniscal lesion (N = 49) 0.046* 1.903 1.012–3.765
Large size 4 cm2 or more (N = 102) 0.030* 1.768 1.017–3.073
*

Statistical significant difference.

4. Discussion

The most important finding of the present study was that many patient-related factors other than the type of surgery performed are important in predicting long-term results. Factors predicting good or excellent result were: A single cartilage lesion; normal appearing cartilage surrounding the lesion; high baseline Lysholm score; short duration of symptoms; non-involvement of the patella-femoral joint; young age at surgery; and small defect size 3 cm2 or smaller. On the other side, factors predicting a poor outcome were: multiple lesions; low baseline Lysholm score; (mild) degenerative cartilage surrounding the lesion; long symptom duration; previous or concomitant partial meniscectomy; and large defect size. Lysholm score were used for evaluation of symptoms and function before surgery and at the most recent follow-up. Lysholm score has been used in many studies of cartilage surgery including microfracture and mosaicplasty11, 15, 17, 20, 21, 22 and has demonstrated overall acceptable psychometric performance for outcomes assessment of various chondral disorders of the knee.19

Treating a single defect was a strong predictor for a good/excellent outcome (OR = 4.0), whereas treating multiple lesions predicted a poor outcome (OR = 2.8). Further, a small (total) defect size predicted a good/excellent outcome (OR = 2.2), whereas a large defect size predicted a poor outcome (OR = 1.8). Many other authors have made similar observations regarding size and/or number of articular cartilage defect(s).12, 17, 21, 22, 23, 24, 25, 26, 27 Thus, there seem to be good scientific support for concluding that treating a single small articular defect offers the best prognosis.

Completely normal appearing articular cartilage surrounding the defect(s) predicted a good/excellent outcome (OR = 2.8), whereas mild degenerative changes14, 15 predicted a poor outcome (OR = 2.3). The finding of poorer outcome in patients with macroscopic signs of degenerative changes in the cartilage surrounding the defect is not surprising as these lesions probably represent a stage closer to the final outcome of many (or all) cartilage lesions, osteoarthritis. However, the classification is rather crude, purely qualitative and subjective, based on the surgeon’s opinion at the time of surgery.15

A high baseline Lysholm score predicted a good/excellent outcome (OR = 2.7), whereas a low baseline Lysholm score predicted a poor outcome (OR = 2.5). Similar observations have been reported earlier.15 The inferior outcome in patients with a poor baseline Lysholm may be explained by the possibility that these lesions represent a more advanced pathology with worse prognosis. And vice versa, a higher baseline Lysholm, may signal a more benign lesion with better prognosis. However, the relationship between the degree of pathology and symptoms is not unambiguously so, since other studies have seen a less clear cut relationship between severity of lesions and outcome evaluated by knee scores.17

A shorter duration of symptoms (<36 months) predicted a good/excellent result (OR = 2.5), whereas a longer duration predicted a poor result (OR = 2.0). Mithöfer et al. reported at a mean 4-year follow-up after autologous chondrocyte transplantation in adolescent athletes that return to preinjury sports correlated with shorter period of preoperative symptoms and a lower number of prior operations. All adolescents with preoperative symptoms 12 months or less returned to preinjury-level athletics, compared to 33% with preoperative intervals longer than 12 months.28 Authors of other studies have made similar findings, as Mithöfer and Della Villa concluded in a meta-analyses involving 20 studies (of different repair techniques) and nearly 1500 patients.29 Solheim et al. a found higher rate of long-term poor outcome after microfracture in a subgroup with long-standing knee symptoms.15

In the current study, lesions that did not involve the patellofemoral predicted a good/excellent outcome (OR = 2.3), but involvement of the patellofemoral joint did not predict a poor outcome (P = 0.2). Cartilage lesions in the patellofemoral joint are generally regarded as more difficult to treat and with worse outcome than lesions on the condyles.10, 30, 31, 32 A study by Karataglis et al., investigating outcomes after OAT procedure (at 3 years postoperatively), however, could not find any difference in the outcome related to different localization of the OATS procedure; on the medial femoral condyle, lateral femoral condyle or the patellofemoral joint.33 Futher, Emre et al. reported good short-term outcome (mean Lysholm score 86) in patellofemoral mosaicplasty, but included no control group.34

We found that partial meniscectomy was a predictor for a poor outcome (OR = 1.9). Other studies have resulted in similar observations.35, 36 Meniscectomy predisposes for osteoarthritis37 and this relationship is the most probable explanation for our finding. In contrast, Bae and co-workers did not find that meniscectomy effected the outcome.26 However, the patients undergoing microfracture in the latter study had osteoarthritis Kellgren-Lawrence grade 3 already at the time of surgery.26

The strengths of the current study include a very high follow-up rate (100%); a large patient population (N = 205); a long follow-up time (median 14 years); the use of prospective collection of data; the inclusion of patient administered outcome score; and identifying determinants for both a good/excellent outcome as well as a poor. The weaknesses include a somewhat inhomogeneous group of patients regarding type of treatment and location of lesions; the lack of randomization of treatment type; and the lack of a control group with a non-surgical treatment strategy. Further, neither a routine second-look arthroscopy nor an MRI examination was performed to evaluate the repair. Lastly, the study does not include routine radiological evaluation of the development of osteoarthritis.

5. Conclusion

The study identifies determinants for both a good/excellent outcome as well as a poor one. Factors other than the choice of surgical method seem to be more important for the long-term outcome after cartilage repair procedures. Knowledge of baseline predictors for the outcome should be of importance for clinicians counselling patient about prognosis after surgery for cartilage injuries of the knee.

References

  • 1.Hjelle K., Solheim E., Strand T., Muri R., Brittberg M. Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy. 2002;18(7):730–734. doi: 10.1053/jars.2002.32839. [DOI] [PubMed] [Google Scholar]
  • 2.Heir S., Nerhus T.K., Røtterud J.H. Focal cartilage defects in the knee impair quality of life as much as severe osteoarthritis: a comparison of knee injury and osteoarthritis outcome score in 4 patient categories scheduled for knee surgery. Am J Sports Med. 2010;38(2):231–237. doi: 10.1177/0363546509352157. [DOI] [PubMed] [Google Scholar]
  • 3.Hunziker E.B., Lippuner K., Keel M.J.B., Shintani N. An educational review of cartilage repair: precepts & practice–myths & misconceptions–progress & prospects. Osteoarthr Cartil. 2015;23(3):334–350. doi: 10.1016/j.joca.2014.12.011. [DOI] [PubMed] [Google Scholar]
  • 4.Karuppal R. Current concepts in the articular cartilage repair and regeneration. J Orthop. 2017;14(2):A1–A3. doi: 10.1016/j.jor.2017.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rodrigo J.J., Steadman J.R., Silliman J.F., Fulstone H.A. Improvement of full-thickness chondral defect healing in the human knee after debridement and microfracture using continuous passive motion. Am J Knee Surg. 1994;(3):109–116. [Google Scholar]
  • 6.Steadman J.R., Rodkey W.G., Singleton S.B., Briggs K.K. Microfracture technique forfull-thickness chondral defects: technique and clinical results. Oper Tech Orthop. 1997;7(4):300–304. [Google Scholar]
  • 7.Hangody L., Kish G., Kárpáti Z., Szerb I., Udvarhelyi I. Arthroscopic autogenous osteochondral mosaicplasty for the treatment of femoral condylar articular defects. A preliminary report. Knee Surg Sports Traumatol Arthrosc. 1997;5(4):262–267. doi: 10.1007/s001670050061. [DOI] [PubMed] [Google Scholar]
  • 8.Løken S., Heir S., Holme I., Engebretsen L., Arøen A. 6-year follow-up of 84 patients with cartilage defects in the knee. Knee scores improved but recovery was incomplete. Acta Orthop. 2010;81(5):611–618. doi: 10.3109/17453674.2010.519166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Goyal D., Keyhani S., Lee E.H., Hui J.H.P. Evidence-based status of microfracture technique: a systematic review of level I and II studies. Arthroscopy. 2013;29(9):1579–1588. doi: 10.1016/j.arthro.2013.05.027. [DOI] [PubMed] [Google Scholar]
  • 10.Kreuz P.C., Steinwachs M.R., Erggelet C. Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthr Cartil. 2006;14(11):1119–1125. doi: 10.1016/j.joca.2006.05.003. [DOI] [PubMed] [Google Scholar]
  • 11.Solheim E., Hegna J., Øyen J., Austgulen O.K., Harlem T., Strand T. Osteochondral autografting (mosaicplasty) in articular cartilage defects in the knee: results at 5 to 9 years. Knee. 2010;17(1):84–87. doi: 10.1016/j.knee.2009.07.007. [DOI] [PubMed] [Google Scholar]
  • 12.Gobbi A., Karnatzikos G., Kumar A. Long-term results after microfracture treatment for full-thickness knee chondral lesions in athletes. Knee Surg Sports Traumatol Arthr. 2014;22(9):1986–1996. doi: 10.1007/s00167-013-2676-8. [DOI] [PubMed] [Google Scholar]
  • 13.Brittberg M., Winalski C.S. Evaluation of cartilage injuries and repair. J Bone Joint Surg Am. 2003;85-A(Suppl. 2):58–69. doi: 10.2106/00004623-200300002-00008. [DOI] [PubMed] [Google Scholar]
  • 14.Spahn G., Klinger H.M., Hofmann G.O. How valid is the arthroscopic diagnosis of cartilage lesions? Results of an opinion survey among highly experienced arthroscopic surgeons. Arch Orthop Trauma Surg. 2009;129(8):1117–1121. doi: 10.1007/s00402-009-0868-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Solheim E., Hegna J., Inderhaug E., Øyen J., Harlem T., Strand T. Results at 10–14 years after microfracture treatment of articular cartilage defects in the knee. Knee Surg Sports Traumatol Arthr. 2016;24(5):1587–1593. doi: 10.1007/s00167-014-3443-1. [DOI] [PubMed] [Google Scholar]
  • 16.Hangody L., Ráthonyi G.K., Duska Z., Vásárhelyi G., Füles P., Módis L. Autologous osteochondral mosaicplasty. Surgical technique. J Bone Joint Surg Am. 2004;86-A(Suppl. 1):65–72. [PubMed] [Google Scholar]
  • 17.Knutsen G., Engebretsen L., Ludvigsen T.C. Autologous chondrocyte implantation compared with microfracture in the knee: a randomized trial. J Bone Joint Surg Am. 2004;86-A(3):455–464. doi: 10.2106/00004623-200403000-00001. [DOI] [PubMed] [Google Scholar]
  • 18.Tegner Y., Lysholm J. Rating systems in the evaluation of knee ligament injuries. Clin Orthop Relat Res. 1985;(198):43–49. [PubMed] [Google Scholar]
  • 19.Kocher M.S., Steadman J.R., Briggs K.K., Sterett W.I., Hawkins R.J. Reliability, validity, and responsiveness of the Lysholm knee scale for various chondral disorders of the knee. J Bone Joint Surg Am. 2004;86-A(6):1139–1145. doi: 10.2106/00004623-200406000-00004. [DOI] [PubMed] [Google Scholar]
  • 20.Knutsen G., Drogset J.O., Engebretsen L. A randomized multicenter trial comparing autologous chondrocyte implantation with microfracture: long-term follow-up at 14 to 15 years. J Bone Joint Surg. 2016;98(16):1332–1339. doi: 10.2106/JBJS.15.01208. [DOI] [PubMed] [Google Scholar]
  • 21.Solheim E., Øyen J., Hegna J., Austgulen O.K., Harlem T., Strand T. Microfracture treatment of single or multiple articular cartilage defects of the knee: a 5-year median follow-up of 110 patients. Knee Surg Sports Traumatol Arthr. 2010;18(4):504–508. doi: 10.1007/s00167-009-0974-y. [DOI] [PubMed] [Google Scholar]
  • 22.Solheim E., Hegna J., Øyen J., Harlem T., Strand T. Results at 10 to 14 years after osteochondral autografting (mosaicplasty) in articular cartilage defects in the knee. Knee. 2013;20(4):287–290. doi: 10.1016/j.knee.2013.01.001. [DOI] [PubMed] [Google Scholar]
  • 23.Peterson L., Minas T., Brittberg M., Nilsson A., Sjögren-Jansson E., Lindahl A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res. 2000;(374):212–234. doi: 10.1097/00003086-200005000-00020. [DOI] [PubMed] [Google Scholar]
  • 24.Gudas R., Simonaitytė R., Cekanauskas E., Tamosiūnas R. A prospective, randomized clinical study of osteochondral autologous transplantation versus microfracture for the treatment of osteochondritis dissecans in the knee joint in children. J Pediatr Orthop. 2009;29(7):741–748. doi: 10.1097/BPO.0b013e3181b8f6c7. [DOI] [PubMed] [Google Scholar]
  • 25.Gomoll A.H. Microfracture and augments. J Knee Surg. 2012;25(1):9–15. doi: 10.1055/s-0031-1299654. [DOI] [PubMed] [Google Scholar]
  • 26.Bae D.K., Song S.J., Yoon K.H., Heo D.B., Kim T.J. Survival analysis of microfracture in the osteoarthritic knee-minimum 10-year follow-up. Arthroscopy. 2013;29(2):244–250. doi: 10.1016/j.arthro.2012.09.006. [DOI] [PubMed] [Google Scholar]
  • 27.Filardo G., Kon E., Perdisa F., Tetta C., Di Martino A., Marcacci M. Arthroscopic mosaicplasty: long-term outcome and joint degeneration progression. Knee. 2015;22(1):36–40. doi: 10.1016/j.knee.2014.10.001. [DOI] [PubMed] [Google Scholar]
  • 28.Mithöfer K., Minas T., Peterson L., Yeon H., Micheli L.J. Functional outcome of knee articular cartilage repair in adolescent athletes. Am J Sports Med. 2005;33(8):1147–1153. doi: 10.1177/0363546504274146. [DOI] [PubMed] [Google Scholar]
  • 29.Mithoefer K., Villa Della S. Return to sports after articular cartilage repair in the football (Soccer) player. Cartilage. 2011;3(1 Suppl):57S–62S. doi: 10.1177/1947603511410419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hangody L., Füles P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J Bone Joint Surg Am. 2003;85-A(Suppl. 2):25–32. doi: 10.2106/00004623-200300002-00004. [DOI] [PubMed] [Google Scholar]
  • 31.Ollat D., Lebel B., Thaunat M. Mosaic osteochondral transplantations in the knee joint, midterm results of the SFA multicenter study. Orthop Traumatol Surg Res. 2011;97(8 Suppl):S160–S166. doi: 10.1016/j.otsr.2011.08.005. [DOI] [PubMed] [Google Scholar]
  • 32.Mouzopoulos G., Borbon C., Siebold R. Patellar chondral defects: a review of a challenging entity. Knee Surg Sports Traumatol Arthr. 2011;19(12):1990–2001. doi: 10.1007/s00167-011-1546-5. [DOI] [PubMed] [Google Scholar]
  • 33.Karataglis D., Green M.A., Learmonth D.J.A. Autologous osteochondral transplantation for the treatment of chondral defects of the knee. Knee. 2006;13(1):32–35. doi: 10.1016/j.knee.2005.05.006. [DOI] [PubMed] [Google Scholar]
  • 34.Emre T.Y., Atbasi Z., Demircioglu D.T., Uzun M., Kose O. Autologous osteochondral transplantation (mosaicplasty) in articular cartilage defects of the patellofemoral joint: retrospective analysis of 33 cases. Musculoskelet Surg. 2017;101(2):133–138. doi: 10.1007/s12306-016-0448-6. [DOI] [PubMed] [Google Scholar]
  • 35.Miller B.S., Steadman J.R., Briggs K.K., Rodrigo J.J., Rodkey W.G. Patient satisfaction and outcome after microfracture of the degenerative knee. J Knee Surg. 2004;17(1):13–17. doi: 10.1055/s-0030-1247141. [DOI] [PubMed] [Google Scholar]
  • 36.Emre T.Y., Ege T., Kose O., Tekdos Demırcıoglu D., Seyhan B., Uzun M. Factors affecting the outcome of osteochondral autografting (mosaicplasty) in articular cartilage defects of the knee joint: retrospective analysis of 152 cases. Arch Orthop Trauma Surg. 2013;133(4):531–536. doi: 10.1007/s00402-013-1680-2. [DOI] [PubMed] [Google Scholar]
  • 37.Love R.J. Prognosis after removal of semilunar cartilages. Br Med J. 1923;2(3269):324–326. doi: 10.1136/bmj.2.3269.324. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Orthopaedics are provided here courtesy of Elsevier

RESOURCES